| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/22/2004 | WO2004007679A2 Dendritic cell pontentiation |
| 01/22/2004 | WO2004007552A1 Cytokine receptor |
| 01/22/2004 | WO2004007547A2 Truncated tau proteins |
| 01/22/2004 | WO2004007540A1 Klebsiella membrane extracts exhibiting advantageous properties, and method for producing said extracts |
| 01/22/2004 | WO2004007539A2 Hsp70 from arthrobacter |
| 01/22/2004 | WO2004007538A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein |
| 01/22/2004 | WO2004007531A2 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | WO2004007525A2 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 01/22/2004 | WO2004006964A1 Microbubble compositions, and methods for preparing and using same |
| 01/22/2004 | WO2004006961A1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 01/22/2004 | WO2004006955A1 Super humanized antibodies |
| 01/22/2004 | WO2004006953A2 Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 01/22/2004 | WO2004006952A2 Therapeutic tuberculosis vaccines |
| 01/22/2004 | WO2004006951A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | WO2004006866A2 Antifungal therapeutic targets |
| 01/22/2004 | WO2004006861A2 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease |
| 01/22/2004 | WO2004006857A2 Glanders/meliodosis vaccines |
| 01/22/2004 | WO2004006855A2 Rhodococcus equi mutants and vaccines comprising same |
| 01/22/2004 | WO2004006853A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | WO2004006851A2 Mycoplasma gallisepticum formulation |
| 01/22/2004 | WO2004006847A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 01/22/2004 | WO2004006837A2 Mesothelin vaccines and model systems |
| 01/22/2004 | WO2003099104A3 Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma |
| 01/22/2004 | WO2003090778A3 Dna vaccine combined with an inducer of tumor cell apoptosis |
| 01/22/2004 | WO2003086289A3 Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors |
| 01/22/2004 | WO2003080792A3 Use of urea-adjuvated polypeptides for diagnosis, prophylaxis and treatment |
| 01/22/2004 | WO2003078595A3 Immunostimulatory double stranded rna and methods of inducing, enhancing or modulating the immune response |
| 01/22/2004 | WO2003076603A3 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions |
| 01/22/2004 | WO2003072800A3 Haemophilus adherence and penetration proteins |
| 01/22/2004 | WO2003070933A3 Process of cell electrofusion |
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003059381A3 Immunogenic preparations and vaccines on the basis of mrna |
| 01/22/2004 | WO2003059380A3 Oral vaccination |
| 01/22/2004 | WO2003048205A3 Novel proteins with il-6 inhibiting activity |
| 01/22/2004 | WO2003045431A3 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist |
| 01/22/2004 | WO2003045316A3 Polynucleotide therapy |
| 01/22/2004 | WO2003041732A3 Contraceptive vaccine compositions comprising a peptide or a plurality of peptides encoded by all or part of the exon 1 of a fsh receptor |
| 01/22/2004 | WO2003041637A3 Lyophilized monoclonal antibody compositions |
| 01/22/2004 | WO2003037919A3 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof |
| 01/22/2004 | WO2003029285A3 Identification of cd8 epitopes from hiv-1 proteins for prevention and therapy of hiv infections |
| 01/22/2004 | WO2003014380A3 Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/22/2004 | WO2002078643A3 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040016004 Novel gene (designated 238P1B2), its encoded protein, and variants thereof exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides diagnostic, prophylactic, therapeutic target for cancer |
| 01/22/2004 | US20040014955 Identification of essential genes of cryptococcus neoformans and methods of use |
| 01/22/2004 | US20040014731 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 01/22/2004 | US20040014715 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/22/2004 | US20040014708 Composition comprising immunogenic microparticles |
| 01/22/2004 | US20040014705 Supplying polypeptides; coupling with controller; therapy for autoimmune disease |
| 01/22/2004 | US20040014697 Melanoma antigenic peptides |
| 01/22/2004 | US20040014663 Botulinum toxin treatment for cervical dystonia |
| 01/22/2004 | US20040014661 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant |
| 01/22/2004 | US20040014207 Dendritic cell potentiation |
| 01/22/2004 | US20040014178 Von willebrand factor-binding proteins from staphylococci |
| 01/22/2004 | US20040014176 Comprises tumor necrosis factor receptor (DCR3) polypeptide for detection, diagnosis and treatment of cancer |
| 01/22/2004 | US20040014172 Comprises retroviral polypeptide for generating genetic vaccine for preventing viral infections; viricides; gene expression inhibition |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014158 Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 01/22/2004 | US20040014155 Composition comprising Phleum pratense pollen (PHl P11) proteins for diagnosis and treatment of atopic disease; immunotherapy; immunoassay |
| 01/22/2004 | US20040014132 Comprises immunoglobulins which binds and neutralizes chemoattractants (eotaxin) for modulating inflammatory response; antiinflammtory agents; antiallergens |
| 01/22/2004 | US20040014127 Compositions and methods for the detection of human T cell receptor variable family gene expression |
| 01/22/2004 | US20040014046 Preparing candidate vaccine agents based on a polypeptide comprising an envelope protein of a pathogenic strain of the retrovirus and selecting as the vaccine a modified polypeptide that induces an immune response |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013740 Antitumor agents for treating tumor of mucosa, skin; poisons are selected from scolopenders, snakes, spiders or scorpions |
| 01/22/2004 | US20040013695 Vaccines; mixture of excipients and antigens; water insoluble antacid as adjuvant; high speed dissolving |
| 01/22/2004 | US20040013692 Use of botulinum toxins for treating various disorders and conditions and associated pain |
| 01/22/2004 | US20040013691 Immunotoxin as a therapeutic agent and uses thereof |
| 01/22/2004 | US20040013690 Attenuated Listeria spp. and methods for using the same |
| 01/22/2004 | US20040013689 Prevention, therapy infectious diseases; insertion of nucleic acids into target cells |
| 01/22/2004 | US20040013687 Complexing Clostridium botulinum; translocation; induction immunology response |
| 01/22/2004 | US20040013686 Surface exposure epitope of loops of Neisseria; induction antibodies; competitive binding |
| 01/22/2004 | US20040013685 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 01/22/2004 | US20040013684 Immunizing against hiv infection |
| 01/22/2004 | US20040013682 Drug design; competitive binding of glycoproteins; vaccines |
| 01/22/2004 | US20040013681 Stimulant of immunology response |
| 01/22/2004 | US20040013680 Neurotoxic oligomers |
| 01/22/2004 | US20040013679 LL-37 is an immunostimulant |
| 01/22/2004 | US20040013677 Mixtures; for therapy, prevention; purity polypeptide |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | US20040013671 Diagnosis, therapy of infections using labeled antibody |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013665 Immunoreactive peptides from Epstein-Barr virus |
| 01/22/2004 | US20040013649 Antitumor agents; nucleic acid, lipid complex |
| 01/22/2004 | US20040013647 Methods and compositions for treating a plaque-forming disease |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | US20040013640 Antitumor agents; rheumatic agents; antiarthritic agents; tissue factor protein binding to antibody |
| 01/22/2004 | US20040013607 Conjugated to Y-90 through aminohexyl diethylenetriaminepentaacetic acid chelating agent |
| 01/22/2004 | DE10230381A1 Verwendung von Inhibitoren der Alanyl-Aminopeptidasen und diese umfassende pharmazeutischen Zubereitungen Use of inhibitors of alanyl-aminopeptidase, and pharmaceutical preparations comprising them |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2532324A1 Microbubble compositions, and methods for preparing and using same |
| 01/22/2004 | CA2493871A1 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2493119A1 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease |
| 01/22/2004 | CA2493111A1 Diagnosis and prevention of cancer cell invasion |
| 01/22/2004 | CA2492856A1 Rhodococcus equi mutants and vaccines comprising same |
| 01/22/2004 | CA2492772A1 Activated checkpoint therapy and methods of use thereof |
| 01/22/2004 | CA2492716A1 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | CA2492561A1 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | CA2492556A1 Hsp70 from arthrobacter |
| 01/22/2004 | CA2492383A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use |